Sarepta Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Sarepta Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
  • Sarepta Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $14.3M, a 88% decline year-over-year.
  • Sarepta Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $24.2M.
  • Sarepta Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$252M, a 64.1% decline from 2022.
  • Sarepta Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$154M, a 477% decline from 2021.
  • Sarepta Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $40.8M, a 267% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$252M -$98.5M -64.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$154M -$195M -477% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $40.8M +$29.7M +267% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $11.1M +$19.4M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$8.32M +$10.7M +56.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$19M -$142M -115% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $123M +$124M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 -$535K -$689K -447% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $154K +$2.15M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 -$2M +$19.7M +90.8% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 -$21.7M +$69.9M +76.3% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-25
2012 -$91.6M -$125M -372% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-26
2011 $33.6M +$44.9M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-03
2010 -$11.2M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.